BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35283357)

  • 21. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
    Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
    Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizures Among Patients With Brain Metastases: A Population- and Institutional-Level Analysis.
    Lamba N; Catalano PJ; Cagney DN; Haas-Kogan DA; Bubrick EJ; Wen PY; Aizer AA
    Neurology; 2021 Feb; 96(8):e1237-e1250. PubMed ID: 33402441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer.
    Shenker RF; McTyre ER; Ruiz J; Weaver KE; Cramer C; Alphonse-Sullivan NK; Farris M; Petty WJ; Bonomi MR; Watabe K; Laxton AW; Tatter SB; Warren GW; Chan MD
    Cancer Med; 2017 May; 6(5):944-952. PubMed ID: 28401684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Press RH; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Burri SH; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):632-638. PubMed ID: 28581405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis.
    Kim M; Suh CH; Lee SM; Park JE; Kim HC; Kim SO; Aizer AA; Yanagihara TK; Bai HX; Guenette JP; Huang RY; Kim HS
    AJR Am J Roentgenol; 2021 Nov; 217(5):1184-1193. PubMed ID: 34037408
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
    J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
    J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors.
    Williams J; Enger C; Wharam M; Tsai D; Brem H
    J Neurooncol; 1998 Mar; 37(1):79-85. PubMed ID: 9525842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Suh JH; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Chao ST
    Pract Radiat Oncol; 2017; 7(4):e263-e273. PubMed ID: 28254368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
    Tsao MN; Xu W; Wong RK; Lloyd N; Laperriere N; Sahgal A; Rakovitch E; Chow E
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003869. PubMed ID: 29365347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery.
    Petrovich Z; Yu C; Giannotta SL; O'Day S; Apuzzo ML
    J Neurosurg; 2002 Dec; 97(5 Suppl):499-506. PubMed ID: 12507085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.